Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer.
Somlo G, Martel CL, Lau SK, Frankel P, Ruel C, Gu L, Hurria A, Chung C, Luu T, Morgan R Jr, Leong L, Koczywas M, McNamara M, Russell CA, Kane SE. Somlo G, et al. Breast Cancer Res Treat. 2012 Feb;131(3):899-906. doi: 10.1007/s10549-011-1850-2. Epub 2011 Nov 1. Breast Cancer Res Treat. 2012. PMID: 22042372 Free PMC article. Clinical Trial.
Combining emerging agents in advanced breast cancer.
Luu T, Chung C, Somlo G. Luu T, et al. Oncologist. 2011;16(6):760-71. doi: 10.1634/theoncologist.2010-0345. Epub 2011 May 4. Oncologist. 2011. PMID: 21543509 Free PMC article. Review.
Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer.
Luu T, Kim KP, Blanchard S, Anyang B, Hurria A, Yang L, Beumer JH, Somlo G, Yen Y. Luu T, et al. Breast Cancer Res Treat. 2018 Jan;167(2):469-478. doi: 10.1007/s10549-017-4516-x. Epub 2017 Sep 27. Breast Cancer Res Treat. 2018. PMID: 28956187 Clinical Trial.
Randomized trial of oral cyclophosphamide versus oral cyclophosphamide with celecoxib for recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Gupta R, Cristea M, Frankel P, Ruel C, Chen C, Wang Y, Morgan R, Leong L, Chow W, Koczywas M, Koehler S, Lim D, Luu T, Martel C, McNamara M, Somlo G, Twardowski P, Yen Y, Idorenyi A, Raechelle T, Carroll M, Chung V. Gupta R, et al. Cancer Treat Res Commun. 2019;21:100155. doi: 10.1016/j.ctarc.2019.100155. Epub 2019 Jul 3. Cancer Treat Res Commun. 2019. PMID: 31279962 Free PMC article. Clinical Trial.
Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial.
Luu T, Frankel P, Beumer JH, Lim D, Cristea M, Appleman LJ, Lenz HJ, Gandara DR, Kiesel BF, Piekarz RL, Newman EM. Luu T, et al. Cancer Chemother Pharmacol. 2019 Dec;84(6):1201-1208. doi: 10.1007/s00280-019-03955-7. Epub 2019 Sep 14. Cancer Chemother Pharmacol. 2019. PMID: 31522242 Free PMC article. Clinical Trial.
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer.
VanderWalde A, Ye W, Frankel P, Asuncion D, Leong L, Luu T, Morgan R, Twardowski P, Koczywas M, Pezner R, Paz IB, Margolin K, Wong J, Doroshow JH, Forman S, Shibata S, Somlo G. VanderWalde A, et al. Biol Blood Marrow Transplant. 2012 Aug;18(8):1273-80. doi: 10.1016/j.bbmt.2012.01.021. Epub 2012 Feb 2. Biol Blood Marrow Transplant. 2012. PMID: 22306735 Free PMC article. Clinical Trial.
74 results